Screener
Eton Pharmaceuticals, Inc. ETON Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by Eton Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.
The source filing: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 4:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001437749-26-017064
FAQ
- What is Eton Pharmaceuticals, Inc.'s accounts receivable?
- Eton Pharmaceuticals, Inc. (ETON) reported accounts receivable of $13.41M in Q1 2026.
- How has Eton Pharmaceuticals, Inc.'s accounts receivable changed year-over-year?
- Eton Pharmaceuticals, Inc.'s accounts receivable decreased by 18.2% year-over-year, from $16.4M to $13.41M.
- What is the long-term trend for Eton Pharmaceuticals, Inc.'s accounts receivable?
- Over 4 years (2021 to 2025), Eton Pharmaceuticals, Inc.'s accounts receivable has grown at a 71.4% compound annual growth rate (CAGR), from $6.46M to $55.69M.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.
Ask your AI about Eton Pharmaceuticals, Inc.'s accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude